This report focusses on challenging the stigma and discrimination experienced by individuals who engage in chemsex, in order that they can equitably enjoy the full range of human rights afforded to all people.
On 20 February 2019, A report released today by the International Drug Policy Consortium (IDPC) has exposed Asia’s war on drugs as a devastating failure.
The third cycle of the Universal Periodic Review (UPR) of the United Nations (UN) Member States began in 2017 and will go on until 2021. In this cycle, the 32nd session of the UPR Working Group in January-February 2019 will hold the review of both Vietnam and Cambodia. As part of the NGO reporting, the following joint submissions were made for both countries on 12 July 2018.
This report outlines the key proceedings of the Training of Trainers (ToT) organised by ANPUD on organisational Development and Advocacy. The training was held from 22 to 25 August 2017 at Hotel Column, Bangkok, Thailand and was attended by twenty-seven participants from Cambodia, India, Vietnam, Nepal, Indonesia, and the Philippines.
The 2017 report comes at a time when the international community has acted decisively to achieve consensus on a way forward for joint action.
The report focuses on hepatitis B and C, which are responsible for 96% of all hepatitis mortality. It presents data along the five strategic directions (strategic information, interventions, equity, financing and innovation) – key pillars of the GHSS to facilitate monitoring of progress in countries, regions and globally, and to measure the impact of interventions on reducing new infections and
saving lives between 2015 and 2030.
Services to reduce drug-related harms are failing to keep up with growing need, despite pledges to combat AIDS among people who inject drugs.
“The right to life is the foundation of all human rights. The taking of life is irreversible, and goes against our fundamental belief in thedignity and worth of every human being. I call on all world leaders, legislators and justiceofficials to stop executions now. There is no place for the death penalty in the 21st century.” – Ban Ki-moon
This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities need to identify the appropriate HCV treatment, and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome.
ANPUD embarked on this project, to begin to investigate and document the barriers to diagnosis, management and treatment of HCV amongst PWID. This investigation and documentation provides some of the necessary foundations for the next steps, in which ANPUD will develop a regional hepatitis C advocacy strategy.